Galera Therapeutics Financials
GRTXDelisted Stock | USD 2.58 0.19 6.86% |
Galera |
Understanding current and past Galera Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Galera Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Galera Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Galera Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Galera Therapeutics. Check Galera Therapeutics' Beneish M Score to see the likelihood of Galera Therapeutics' management manipulating its earnings.
Galera Therapeutics Stock Summary
Galera Therapeutics competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, and Hookipa Pharma. Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Galera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.Specialization | Healthcare, Biotechnology |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US36338D1081 |
CUSIP | 36338D108 |
Location | Pennsylvania; U.S.A |
Business Address | PO Box 134, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.galeratx.com |
Phone | 610 725 1500 |
Currency | USD - US Dollar |
Galera Therapeutics Key Financial Ratios
Return On Equity | -10.63 | ||||
Return On Asset | -0.59 | ||||
Target Price | 0.5 | ||||
Beta | 2.03 |
Galera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Galera Therapeutics's current stock value. Our valuation model uses many indicators to compare Galera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Galera Therapeutics competition to find correlations between indicators driving Galera Therapeutics's intrinsic value. More Info.Galera Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Galera Therapeutics' earnings, one of the primary drivers of an investment's value.Galera Therapeutics Market Pulse
Quote | 2.58 |
Change(%) | 6.86 |
Change | 0.19 |
Open | 2.77 |
Low | 2.54 |
High | 2.77 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Galera Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Galera has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Galera Therapeutics' financials are consistent with your investment objective using the following steps:- Review Galera Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Galera Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Galera Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Galera Therapeutics' stock is overvalued or undervalued.
Galera Therapeutics November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Galera Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Galera Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Galera Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Galera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Galera Therapeutics's daily price indicators and compare them against related drivers.
Information Ratio | (0.04) | |||
Maximum Drawdown | 18.16 | |||
Value At Risk | (5.84) | |||
Potential Upside | 7.31 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Galera Stock
If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |